Health Condition 1: L817- Pigmented purpuric dermatosis
Conditions
Interventions
Intervention1: Q switched neodymium doped yttrium aluminum garnet laser: Q switched neodymium doped yttrium aluminum garnet laser at 1064 nanometer with fluence 600 milijoule per pulse and spot size 5
Sponsors
Bankura Sammilani Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Age more than 18 years to 80 years. Pigmented purpuric dermatosis patients who have not received any treatment since 1 month. Pigmentation present bilaterally on the lower limbs.
Exclusion criteria
Exclusion criteria: Pregnant and lactating women. Patients having pigmented purpuric dermatosis at sites other than lower limbs. Those having any skin disease other than pigmented purpuric dermatosis on the lower limb(s). Patients with psychiatric disorders. Participation in any clinical trial within the last 3 months. Non-consenting patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Q switched neodymium doped yttrium aluminum garnett laser will be more effcetive in reducing pigmentation of pigmented purpuric dermatosis , compared to placebo on the basis of decline in skin hyperpigmentation index.Timepoint: 16 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The safety of Q switched neodymium doped yttrium aluminum garnett laser will be evaluated in patients with pigmented purpuric dermatosis , compared to placebo on the basis of adverse events noted.Timepoint: 16 weeks | — |
Countries
India
Contacts
Public ContactDR. ANIRBAN MUKHERJEE
Department of Dermatology, Bankura Sammilani Medical College
Outcome results
None listed